The California startup is about to launch its first product, a noninvasive prenatal screening test for recessive single-gene disorders called Unity.
CRISPR Therapeutics Licenses Cell Engineering Platform From MaxCyte
The firm will use MaxCyte's cell transfection platform to edit hematopoietic stem cells with CRISPR/Cas9 in hemoglobinopathy and SCID.
CRISPR Editing of Hemoglobin Gene Shows Utility of Ribonucleoproteins in Hematopoetic Stem Cells
Utah's Dana Carroll, UC Berkeley's Jacob Corn, and their colleagues replaced the sickle cell disease mutation with the wild-type gene via HDR.
PerkinElmer to Distribute Sebia Newborn Screening System
NEW YORK (GenomeWeb) – PerkinElmer has signed an agreement to serve as the exclusive global distributor for Sebia's Capillarys 2 Neonat Fast system for labs conducting newborn screening.
Bruker, GBC Proteomics Centre Protein Assay Deal Points to New Clinical Markets for MALDI Biotyper
Bruker and the University of Victoria-Genome British Columbia Proteomics Centre said this week that they are collaborating on high-throughput iMALDI mass spec-based assays for determining genetic hemoglobin variants and diabetes risk.
Jan 12, 2012